Ferid Murad, born September 14, 1936 in Whiting, Indiana, USA
Address: Department of Integrative Biology, Pharmacology and Physiology, University of Texas Medical School at Houston, P.O. Box 20708, Houston, TX 77225, USA
1958-65 M.D., Western Reserve University, School of Medicine, Cleveland, OH
1958-65 Ph.D., Department of Pharmacology, Western Reserve University, School of Medicine, Cleveland, OH
Appointments and Professional Activities
1975-81 Professor, Depts of Internal Medicine and Pharmacology, Univ of Virginia School of Medicine, Charlottesville, VA
1971-81 Director, Clinical Research Center, Univ of Virginia, Charlottesville, VA
1973-81 Director, Division of Clinical Pharmacology, Dept of Internal Medicine, Charlottesville, VA
1981-89 Professor, Departments of Internal Medicine and Pharmacology, Stanford Univ, Stanford, CA
1981-86 Chief of Medicine, Palo Alto Veterans Administration Medical Center, CA
1988- Professor (Adjunct), Department of Pharmacology, Northwestern Univ Medical School, Chicago, Illinois
1990-92 Vice President, Pharmaceutical Research & Development, and Corporate Officer, Abbott Laoratories, Abbott Park, Illinois
1993-95 CEO/President, Molecular Geriatrics Corporation, Lake Bluff, Illinois
Fellowships and Awards
Ciba Award Recipient, 1988
Albert Lasker Basic Medical Research Award, 1996
The Nobel Assembly at the Karolinska Institute
Hartmut Michel, (born July 18, 1948, Ludwigsburg, W.Ger.), German biochemist who, along with Johann Deisenhofer and Robert Huber, received the Nobel Prize for Chemistry in 1988 for their determination of the structure of certain proteins that are essential for photosynthesis.
Michel earned his doctorate from the University of Würzburg in 1977. In 1979 he joined the staff of the Max Planck Institute for Biochemistry in Martinsried, W.Ger., where he conducted his award-winning research. He became head of the Max Planck Institute for Biophysics in Frankfurt am Main in 1987.
It was Michel’s preliminary work, done in the period from 1978 to 1982, that cleared the way for the three scientists’ joint research. They wanted to determine the three-dimensional structure of a four-protein complex (called a photosynthetic reaction centre) that is crucial to the process of photosynthesis in certain bacteria. Michel performed the hitherto impossible feat of crystallizing the membrane-bound protein complex to a pure crystalline form, thus making it possible to determine the protein’s structure atom-by-atom by means of X-ray diffraction techniques.
Dr. Q. Ping Dou is Professor of Oncology, Pharmacology and Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA. Dr. Dou obtained his B.S. degree in chemistry from Shandong University (PR China) in 1981, Ph.D. degree in chemistry from Rutgers University in 1988, and postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School from 1988 to 1993 (Mentor: Arthur B. Pardee). Dr. Dou has extensive experience in the fields of drug discovery, chemoprevention, natural products, proteasome inhibitors, cell cycle and apoptosis. He has published ~200 peer-reviewed research and review articles, many of those in journals of the highest quality, and also holds ~10 patents. He has extensive experience in professional service, including various study sections, several advisory and editorial boards, and committees. He has mentored numerous graduate students, post-doctoral fellows and junior faculty.
Institution: Departamento de Química Fundamental, Instituto de Química, Universidade de São Paulo
Av. Prof. Lineu Prestes, 748, B2T, CEP: 05508-000, São Paulo, SP, Brasil.
02 Patents request; Author of 04 Books, Translator and Technical Reviewer of other 04 books.
- More than 130 participations in Scientific Events in Brazil and many countries in the world, with posters and oral presentations
- More recent Invited Oral Presentation: Denise de Oliveira Silva. Novel Class of Ruthenium-Therapeutic Drugs and Implications for Cancer.
In: BIT 2nd Annual International Conference of Medichem-2011 (ICM-2011) - Theme: Smart Chemistry in Drug Discovery, Book of Program and Abstracts of ICM-2011, p 065, Beijing, China, 2011. Oral Presentation by Denise de Oliveira Silva on Track 1: Biosciences and Chemical Biology & Medicinal Chemistry, Session 1-6: Oncology and Medicinal Chemistry, Beijing, China, 2011.
Dr. Debomoy Lahiri is Professor at Indiana University School of Medicine, USA. His major research focus is to understand the mechanism of aging, origin and biogenesis of the amyloid plaque, and to discover drug targets for Alzheimer's disease (AD) and other brain disorders. Dr. Lahiri’s group has shown the novel role of specific microRNA species in regulation of genes implicated in AD as well as the role of gene and environment interaction in late-life disorders. Also, his team has made significant contributions to understanding the biochemical pathway for neurodevelopment disorders, such as autism and fragile X syndrome. Dr. Lahiri is the Editor-In-Chief of the international journal, ‘Current Alzheimer Research' (Bentham). He authored books, such as ‘Protective Strategies for Neurodegenerative Diseases' published by the New York Academy of Sciences. Dr. Lahiri was awarded grants as a Principal Investigator from the National Institute on Aging, NIH, and Alzheimer’s Association, USA. His other honors include the ‘Zenith Award’ and listing in Marquis' ‘Who's Who in the World'.
International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry and Dr. Panjwani Center for Molecular Medicine and Drug Research, University of Karachi, Karachi-75270, Pakistan.